Recent Updates
Recently added Catalysts
BMY Neutral Sentiment

Bristol Myers Squibb Announces Dividend

Key Takeaway: Bristol Myers Squibb has announced a dividend, indicating a commitment to returning value to shareholders. However, the article lacks specific details about the dividend amount or the context surrounding this decision. The announcement reflects the company's ongoing financial strategy.
Price reaction · baseline $55.28 (2026-06-17 close) · hit after-hours · 1 other BMY headline(s) in the window, move may be shared
day 0 close · peak
-2.3%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company.
The dividend is payable on August 3, 2026, to stockholders of record at the close of business on July 2, 2026.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit us atBMS.comand follow us onLinkedIn,X,YouTube,Facebook, and Instagram.
corporatefinancial-news
Last updated: Jun 17, 2026